SCHEMBL2115464

SCHEMBL2115464

N#Cc1ccc2cc(Cl)cc(-c3cccc4ccccc34)c2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS2 Q07890 1/20 0.43
PIM1 P11309 4/20 0.41
MET P08581 4/20 0.40
KDM4E B2RXH2 3/20 0.38
ALOX15 P16050 5/20 0.37
SRC P12931 1/20 0.36
GPR84 Q9NQS5 1/20 0.36
ALDH1A1 P00352 2/20 0.36
HSD17B10 Q99714 2/20 0.36
MCL1 Q07820 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
MEN1 O00255 1/20 0.35
HCRTR1 O43613 1/20 0.35
GLA P06280 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2118311 0.84 PIM1 (0.46) SOS2PIM1KDM4EALOX15SRC
SCHEMBL2117674 0.84 SOS2 (0.43) SOS2PIM1METKDM4EALOX15
SCHEMBL2116327 0.81 PIM1 (0.42) PIM1KDM4EGPR84ALDH1A1HSD17B10
SCHEMBL2116276 0.79 CTSB (0.43) SOS2PIM1KDM4EALDH1A1RAB9A
SCHEMBL2116537 0.77 PIM1 (0.50) SOS2PIM1KDM4EALDH1A1MCL1
SCHEMBL2116777 0.76 ALOX15 (0.49) SOS2ALOX15SRCALDH1A1RAB9A
SCHEMBL2118134 0.75 FDPS (0.52) KDM4EGPR84ALDH1A1MCL1MEN1
SCHEMBL3341584 0.72 SOS2 (0.59) SOS2METKDM4ESRCALDH1A1
SCHEMBL2115951 0.71 ALDH1A1 (0.46) KDM4EALOX15SRCALDH1A1HSD17B10
SCHEMBL737612 0.68 ALOX15 (0.46) SOS2PIM1KDM4EALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120094958-A1 QUINOLINES AS INHIBITORS OF FARNESYL PYROPHOSPHATE SYNTHASE NOVARTIS AG (CH) 2012-04-19 US disclosed
CN-101959865-A Quinolines as farnesyl pyrophosphate synthase inhibitor NOVARTIS AG 2011-01-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120094958-A1 QUINOLINES AS INHIBITORS OF FARNESYL PYROPHOSPHATE SYNTHASE FDPS, GGPS1, CTPS1 SOS2 1622/4885PIM1 2265/4885MET 3712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.